Johnson & Johnson (LON:0R34)

Market Cap	337.12B
Revenue (ttm)	66.08B
Net Income (ttm)	16.52B
Shares Out	n/a
EPS (ttm)	6.81
PE Ratio	20.40
Forward PE	17.26
Dividend	3.90 (2.06%)
Ex-Dividend Date	Aug 26, 2025

Volume	19,569
Average Volume	7,193
Open	185.73
Previous Close	185.99
Day's Range	185.73 - 189.75
52-Week Range	138.93 - 189.75
Beta	n/a
RSI	76.66
Earnings Date	Oct 14, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 138,100
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R34

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD